公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
2014 | Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome | HSIN-AN HOU ; Kuo Y.-Y.; WEN-CHIEN CHOU ; Chen P.-H.; HWEI-FANG TIEN | Leukemia | 7 | 7 | |
2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 | |
2010 | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | HSIN-AN HOU ; TIFFANY TING-FANG SHIH ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; CHAO-YU HSU ; HWEI-FANG TIEN | Haematologica | 14 | 14 | |
2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; Chen, Chien-Yuan ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Leukemia | 58 | 54 | |
2013 | Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence-clinical implication and comparison between the West and the East | SHANG-JU WU ; Lin, Chien-Ting; Huang, Sheng-Yi; Lee, Fen-Yu; Liu, Ming-Chi; HSIN-AN HOU ; Chen, Chien-Yuan ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Ann. Hematol. | 12 | 10 | |
2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Yu-Hung Wang; HSIN-AN HOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; CHI-YUAN YAO ; CHIA-LANG HSU ; Mei-Hsuan Tseng; CHENG-HONG TSAI ; Yen-Ling Peng; Chein-Jun Kao; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood advances | 14 | 15 | |
2022 | The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression | CHI-YUAN YAO ; CHIEN-CHIN LIN ; Wang, Yu-Hung; Hsu, Chia-Lang; Kao, Chein-Jun; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | CHENG-HONG TSAI ; JIH-LUH TANG ; FENG-MING TIEN ; YUAN-YEH KUO ; Wu D.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; CHIA-WEN LIU ; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood Advances | 27 | 27 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2022 | Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma | Hsu C.-J.; HSIN-AN HOU ; CHANG-PING LIN ; Lee Y.-J.; Hsu W.-F.; PO-TING YEH | Journal of the Formosan Medical Association | 1 | 1 | |
2016 | Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection | WEI-LI MA ; HSIN-AN HOU ; Hsu, Ya-Jui; YIN-KAI CHEN ; JIH-LUH TANG ; WOEI TSAY ; PO-TING YEH ; CHUNG-MAY YANG ; CHANG-PING LIN ; HWEI-FANG TIEN | Annals of Hematology | 43 | 37 | |
2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | HSIN-AN HOU ; Lu J.-W.; Lin T.-Y.; CHENG-HONG TSAI ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; JIH-LUH TANG ; Gong Z.; LIANG-IN LIN ; HWEI-FANG TIEN | Blood cancer journal | 15 | | |
2023 | Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; FENG-MING TIEN ; Lo, Min-Yen; Ni, Sao-Chih; MING YAO ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 3 | |
2016 | Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia | Madan V.; Shyamsunder P.; Han L.; Mayakonda A.; Nagata Y.; Sundaresan J.; Kanojia D.; Yoshida K.; Ganesan S.; Hattori N.; Fulton N.; Tan K.-T.; Alpermann T.; Kuo M.-C.; Rostami S.; Matthews J.; Sanada M.; Liu L.-Z.; Shiraishi Y.; Miyano S.; Chendamarai E.; HSIN-AN HOU ; Malnassy G.; Ma T.; Garg M.; Ding L.-W.; Sun Q.-Y.; Chien W.; Ikezoe T.; Lill M.; Biondi A.; Larson R.A.; Powell B.L.; Lübbert M.; Chng W.J.; HWEI-FANG TIEN ; Heuser M.; Ganser A.; Koren-Michowitz M.; Kornblau S.M.; Kantarjian H.M.; Nowak D.; Hofmann W.-K.; Yang H.; Stock W.; Ghavamzadeh A.; Alimoghaddam K.; Haferlach T.; Ogawa S.; Shih L.-Y.; Mathews V.; Koeffler H.P. | Leukemia | 95 | 64 | |
2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |